How Specialty Pharmacists Can Prepare Patients to Switch to Biosimilars

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Related Content:

InterviewsBiosimilarsRheumatoid ArthritisSpecialty Pharmacy
Researchers Explore More Safe and Effective CAR T-Cell Therapy for Cancer Treatment
Targeted Therapies Could Be Key to Treating Myelodysplastic Syndrome
Researchers Explore Approaches to Block T-Cell Exhaustion